Prosecution Insights
Last updated: April 19, 2026

Nepenthe Bioscience LLC

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17382821 Anti-CD79 Antibodies and Their Uses TAYLOR, LIA ELAN 1641 Final Rejection Jul 22, 2021

Managing Nepenthe Bioscience LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month